These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4142059)

  • 21. Interview with John Fitzpatrick--combination therapy for BPH: is this the way forward? Interview by Christine McKillop.
    Fitzpatrick J
    Eur Urol; 2006 Mar; 49(3):581-3. PubMed ID: 16459015
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experience with SH 582 for prostatic hypertrophy; comparison with estrogen therapy].
    Terao N; Ogawa I; Fujimura N; Kondo K; Tsumagari I
    Hinyokika Kiyo; 1970 Sep; 16(9):523-30. PubMed ID: 4097364
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hormonal disturbances in men with a prostatic adenoma (author's transl)].
    Baranowska B; Zgliczynski S; Szymanowski J
    J Urol (Paris); 1980; 86(7):551-8. PubMed ID: 6161196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current state of the surgical treatment of benign prostatic hypertrophy].
    Pagano F
    J Urol (Paris); 1993; 99(6):362-3. PubMed ID: 7516392
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hormone therapy for prostatic carcinoma and hypertrophy].
    Hanschke HJ
    Dtsch Med Wochenschr; 1969 Mar; 94(13):677-8. PubMed ID: 4180637
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experiences in the treatment of prostatic hypertrophy with high doses of progesterone administered rectally].
    Marini A; Cavalca GG
    Minerva Urol; 1974; 26(3):140-5. PubMed ID: 4138638
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current methods in the treatment of prostatic hyperplasia].
    Kontturi M
    Nord Med; 1993; 108(4):107-10. PubMed ID: 7683132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficacy of a mixture of three hormones in the therapy of climacteric syndromes].
    PASETTO N; ERMIGLIA G; VASSALLO E
    Quad Clin Ostet Ginecol; 1955 Mar; 10(3):177-82. PubMed ID: 14395398
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pre- and post-prostatectomy variation and supplement of sexual hormones in patients with benign prostatic hyperplasia].
    Ren XM; Ying J; Yao DH; Jiang YQ; Xu MX
    Zhonghua Nan Ke Xue; 2005 Jan; 11(1):50-2, 55. PubMed ID: 15704683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enzyme inhibition in the drug therapy of benign prostatic hyperplasia].
    Drsata J
    Cas Lek Cesk; 2002 Oct; 141(20):630-5. PubMed ID: 12515038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conservative and surgical management of prostatic diseases].
    Hubmann R; Opelt B
    Internist (Berl); 1968 May; 9(5):207-13. PubMed ID: 4178136
    [No Abstract]   [Full Text] [Related]  

  • 32. [Estrogen-progesterone therapy in glandular cystic hyperplasia and adenomatosis of the endometrium].
    Hernandez Pineda P; Reyes Ceja L; Karchmer S; Valenzuela S; Zarate A
    Ginecol Obstet Mex; 1968 Jun; 23(140):707-17. PubMed ID: 5739481
    [No Abstract]   [Full Text] [Related]  

  • 33. What is the best medical treatment for benign prostate hyperplasia?
    Evans MF; Frank J
    Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295
    [No Abstract]   [Full Text] [Related]  

  • 34. Estrogenic management of benign prostatism, including early and poor-risk cases. 7-year experience.
    Roberts HJ
    J Am Geriatr Soc; 1966 Jul; 14(7):657-701. PubMed ID: 4160996
    [No Abstract]   [Full Text] [Related]  

  • 35. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
    [No Abstract]   [Full Text] [Related]  

  • 36. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
    Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
    MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conference on the treatment of cancer of the prostate].
    Richaud C
    J Urol Nephrol (Paris); 1968; 74(10):769-87. PubMed ID: 4178295
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 39. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

  • 40. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA; Vinarov AZ
    Urol Nefrol (Mosk); 1996; (4):25-7. PubMed ID: 8928344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.